Jupiter Topco LLC acquired a new position in shares of Humana Inc. (NYSE:HUM – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 212,346 shares of the insurance provider’s stock, valued at approximately $84,347,000.
Several other large investors have also recently bought and sold shares of the company. Wilkerson Advisory Group LLC grew its holdings in shares of Humana by 24.6% during the second quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock worth $66,000 after purchasing an additional 33 shares during the last quarter. Bogart Wealth LLC raised its holdings in Humana by 192.0% in the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares during the last quarter. Fiduciary Alliance LLC boosted its position in Humana by 0.9% during the 1st quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock worth $976,000 after buying an additional 49 shares during the period. Sanctuary Advisors LLC boosted its position in Humana by 1.6% during the 4th quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock worth $868,000 after buying an additional 52 shares during the period. Finally, Horizon Investments LLC grew its holdings in Humana by 2.5% during the 4th quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock worth $573,000 after acquiring an additional 55 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on HUM shares. Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target for the company in a research note on Thursday, July 30th. Lake Street Capital assumed coverage on shares of Humana in a research note on Thursday, July 30th. They issued a “buy” rating on the stock. Wells Fargo & Company upgraded Humana from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $227.00 to $502.00 in a report on Monday, July 13th. Royal Bank Of Canada raised their target price on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 9th. Finally, William Blair initiated coverage on Humana in a report on Wednesday, May 20th. They set an “outperform” rating on the stock. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $403.91.
Humana Stock Performance
HUM stock opened at $390.06 on Thursday. The firm has a market cap of $46.84 billion, a PE ratio of 36.90, a price-to-earnings-growth ratio of 2.22 and a beta of 0.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The stock has a 50-day moving average price of $384.44 and a 200-day moving average price of $286.38. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88.
Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the prior year, the company earned $6.27 EPS. The firm’s revenue for the quarter was up 26.2% compared to the same quarter last year. As a group, equities research analysts expect that Humana Inc. will post 9.12 earnings per share for the current year.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Further Reading
- Five stocks we like better than Humana
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
